This inventor holds 1 USPTO granted patent. Top assignee: Sapporo Breweries Limited. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Ryoichi Sato: Innovator in Antitumor Compounds
Introduction
Ryoichi Sato is a notable inventor based in Yaizu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor substances. His innovative work has led to the creation of novel compounds that hold promise for cancer treatment.
Latest Patents
Ryoichi Sato holds a patent for HP530 compounds and the process for preparing the same. This patent discloses novel HP530 compounds, their derivatives, or their pharmaceutically permissible salts. The process involves cultivating Streptomyces sp. HP530 (FERM BP-2786) or chemically deriving these compounds. The HP530 compounds are expressed by a specific general formula, which includes various acyl groups and other chemical structures.
Career Highlights
Sato is associated with Sapporo Breweries Limited, where he has been able to apply his expertise in the development of pharmaceutical compounds. His work has been instrumental in advancing the understanding and application of antitumor agents.
Collaborations
Some of Ryoichi Sato's coworkers include Yasukazu Nakakita and Suguru Takeo. Their collaborative efforts have contributed to the success of the projects they have undertaken together.
Conclusion
Ryoichi Sato's innovative work in the field of antitumor compounds showcases his dedication to advancing medical science. His contributions are significant and reflect the importance of research in developing effective treatments for cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile